For four decades, the causal link between RAS mutations in cancer – including the KRAS, HRAS, and NRAS genes – has been well-accepted. But for almost as long, oncology drug development has struggled to develop RAS inhibitors, and many had long...

Our Mission
Connecting every patient to the right therapy for their cancer, the first time, every time.
Learn More About Certis
Our Mission
Connecting every patient to the right therapy for their cancer, the first time, every time.
Learn More About Certis